Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting

Ashley E. Kim; Julia C. Bennett; Kyle G Luiten; Jessica O’Hanlon; Caitlin R. Wolf; Ariana Magedson; Peter D. Han; Zack Acker; Lani Regelbrugge; Kathryn McCaffrey; Jeremey Stone; David Reinhart; Benjamin J. Capodanno; Stephen S. Morse; Trevor Bedford; Janet A. Englund; Michael Boeckh; Lea M. Starita; Timothy M. Uyeki; Marco Carone; Ana A. Weil; Helen Y. Chu

doi:10.1093/infdis/jiae150

Abstract

SARS-CoV-2 antigen-detection rapid diagnostic tests (Ag-RDTs) have become widely utilized but longitudinal characterization of their community-based performance remains incompletely understood.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kim et al. (2024) studied this question.

synapsesocial.com/papers/68e7243cb6db64358769e395 https://doi.org/10.1093/infdis/jiae150

View Full Paper

Ask AI

Bookmark

Abstract

SARS-CoV-2 antigen-detection rapid diagnostic tests (Ag-RDTs) have become widely utilized but longitudinal characterization of their community-based performance remains incompletely understood.

Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting

Abstract

Discussion

Cite This Study

Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting

Abstract

Discussion

Cite This Study

Keep reading

Keep reading